Search results for: 'software as a service transaction'
- Related search terms
- Software-Defined Instruments and Reinvented Business Models to Impact Market Outlook, Communication Test Revenues to Soar
- services markets
- software as a medical device the new frontier for growth for med tech oems
- services 20 advanced services
- services market
-
28 Mar 2019  |  Asia Pacific  |  Market Research
Thailand Clinical Laboratories Market, Forecast to 2025
Rising Demand for Diagnostics Services from the Ageing Population and Growing Prevalence of Chronic Diseases to Drive Market Growth
This study focuses on clinical lab services in Thailand. A detailed analysis is provided on clinical testing services at public hospital labs and private hospital labs. Specialised labs are integrated into the independent reference labs segment. Certain trends with regard to physician office labs (POLs) in retail clinics have been mentioned in the ...
$1,500.00
Special Price $1,125.00 save 25 %
-
09 Sep 2021  |  North America  |  Market Research
Global Medical Device Leasing Growth Opportunities
Vendors' Integration of Support Services and Shift from Product-centric to Value-oriented Business Models will Improve ROI and Mar
Globally, hospitals and health systems face financial pressure caused by high operating and administrative costs, declining revenue and reimbursement rates, and the increasing cost of both medical devices (due to technology advancements) and infrastructure. The COVID-19 pandemic has intensified this financial crisis as patient volumes dropped and n...
$2,450.00
Special Price $1,837.50 save 25 %
-
31 Jan 2022  |  North America  |  Market Research
Global Digital Health Investments Growth Opportunities
On-demand Healthcare Services and AI-enabled Care Delivery Enable Future Growth Potential
Frost & Sullivan observed a significant increase in the digital transformation of healthcare and demand for effective IT solutions to improve care delivery, creating a lot of excitement among investors. Venture capitalist activities in health technology rise as healthcare organizations, clinical trial providers, insurance firms, employers, and poli...
$2,450.00
Special Price $1,837.50 save 25 %
-
15 Dec 2020  |  North America  |  Market Research
Transition to Hybrid Cloud Services to Trigger the Growth of Laboratory Information Management Systems in the United States and European Union, 2020
Thriving Demand for Biorepositories and Maturity of the Biobanking Industry to Unlock New Growth Opportunities
The Transformational Health team at Frost & Sullivan provides critical insights into the US and EU laboratory information management system (LIMS) industry, highlighting the key growth opportunities, market revenue forecast, and trends that will play an important role in industry growth. The US and EU LIMS market covered in this study is segmented...
$4,950.00
Special Price $3,712.50 save 25 %
-
31 Jan 2020  |  North America  |  Market Research
Predictions for the Global Life Sciences Industry, 2020
COVID-19 Pandemic will Drive New Digital-tech Adoption in Drug Discovery and Testing Services, and Federal Funding will Encourage Stronger Product Pipelines
The growth trajectory of the global life sciences industry has benefited from a combination of novel technologies such as CRISPR-Cas9, microbiome and single-cell, relaxation of entry barriers in markets like China, and better-defined regulatory frameworks around next-generation therapies and companion diagnostics. A common denominator of growth a...
$1,500.00
Special Price $1,125.00 save 25 %
-
23 Aug 2013  |  Europe  |  Market Research
Analysis of the Hospital Information Systems (HIS) Market in Europe
Predictions in HIS Through 2019
This research study provides an understanding of the healthcare information systems (HIS) within the context of the European market. HIS can be broadly segmented into clinical and non-clinical segments as well as into software and services segments, based on vendor product and service offerings. The scope for Europe includes the United Kingdom, Ger...
$4,950.00
Special Price $3,712.50 save 25 %
-
15 Nov 2023  |  Global  |  Market Research
Global Precision Oncology Market Trends and Growth Opportunities
Public-private Partnerships Will Propel Access and Adoption of Precision Oncology Enhancing the Potential for Integrated Services and Solutions
The procedure for accurately identifying a biomarker correlation based on a patient s genetic makeup is complex and relies on the expertise and knowledge of an oncologist, decision-support scientist, or other healthcare professional involved in the matching process. Precision oncology aims to provide oncologists with diagnosis, prognosis, and treat...
$2,450.00
Special Price $1,837.50 save 25 %
-
01 Jul 2004  |  North America  |  Market Research
CRM Markets for the U.S. Pharmaceutical Industry
This report provides a concise graphic snapshot of the changing face of the products and services which comprise the Customer Relationship Management market for U.S. pharmaceutical organizations from 2004-2007. It includes a breakdown of sub-markets, including SFA software, marketing/back office analytics software, and call center services. Each su...
$2,450.00
Special Price $1,837.50 save 25 %
-
19 Dec 2022  |  North America  |  Market Research
PCR-based PoC Platforms for Infectious Disease Testing Growth Opportunities
Multimodal and Multiplex Platforms are Expanding the Molecular PoC Testing Ecosystem
Since the onset of the COVID-19 pandemic, molecular diagnostics mergers/acquisition transactions and product launches for infectious disease testing are indicating a pivot toward a new direction or an enhancement of portfolios. The emergence of saliva sample testing and the transition to PCR-based syndromic and direct-to-consumer testing for respir...
$2,450.00
Special Price $1,837.50 save 25 %
-
25 Jun 2024  |  Global  |  Market Research
Growth Opportunities in Biologics Contract Development and Manufacturing Organizations, 2024 2029
Risk-sharing Business Models for Next-generation Biologics Will Drive Bio-CDMO Growth and Spur Future Potential
By 2023, biologics constituted 44% of the therapeutic pipeline, with antibodies and recombinant proteins as leading categories. Nevertheless, advancements in these fields decelerated, with most of the expansion happening in heterologous cell treatments, synthetic nucleic acids, and viruses. The global biologics pipeline will shift toward more compl...
$4,950.00
Special Price $3,712.50 save 25 %